PER 2.86% 7.2¢ percheron therapeutics limited

Very interesting, thanks for this. Having CD49+ as the...

  1. 4,336 Posts.
    lightbulb Created with Sketch. 2023
    Very interesting, thanks for this. Having CD49+ as the biomarker, and not dystrophin will probably aid in any combination trial, or treatment post gene therapy.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.002(2.86%)
Mkt cap ! $64.91M
Open High Low Value Volume
7.4¢ 7.4¢ 7.0¢ $44.32K 616.8K

Buyers (Bids)

No. Vol. Price($)
1 4250 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 49809 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.